Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Total Non-Current Liabilities came in at -$89.9 million in Q1 2026, down 3.36% year-on-year from -$93.0 million in Q1 2025, and down 2.44% on a QoQ basis from -$87.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Total Non-Current Liabilities data on file, last reported at -$89.9 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 3.36% year-over-year to -$89.9 million in Q1 2026; TTM through Mar 2026 was -$89.9 million, a 3.36% decrease from a year earlier, with the FY2025 full-year figure at -$87.8 million, up 3.71% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at -$89.9 million, down from -$87.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for STVN reached as high as -$39.3 million in Q2 2022 and fell as low as -$91.2 million in Q3 2025.
- Historically, Total Non-Current Liabilities has averaged -$73.3 million across 5 years, with a median of -$78.8 million in 2024.
- Across the five-year window, Total Non-Current Liabilities slumped 116.16% in 2022 and grew 3.71% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at -$54.0 million in 2022, then tumbled by 38.55% to -$74.8 million in 2023, then declined by 21.9% to -$91.2 million in 2024, then increased by 3.71% to -$87.8 million in 2025, then retreated by 2.44% to -$89.9 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were -$89.9 million in Q1 2026, -$87.8 million in Q4 2025, and -$91.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | -89.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.91 Mn |
| Dec 31, 2025 | -87.77 Mn |
| Sep 30, 2025 | -91.19 Mn |
| Jun 30, 2025 | -88.41 Mn |
| Mar 31, 2025 | -86.99 Mn |
| Dec 31, 2024 | -91.15 Mn |
| Sep 30, 2024 | -81.38 Mn |
| Jun 30, 2024 | -78.83 Mn |
| Mar 31, 2024 | -78.65 Mn |
| Dec 31, 2023 | -74.78 Mn |
| Sep 30, 2023 | -80.45 Mn |
| Jun 30, 2023 | -74.05 Mn |
| Mar 31, 2023 | -57.32 Mn |
| Dec 31, 2022 | -53.97 Mn |
| Sep 30, 2022 | -51.02 Mn |
| Jun 30, 2022 | -39.27 Mn |
| Mar 31, 2022 | -41.41 Mn |
| Dec 31, 2021 | -41.53 Mn |
| Sep 30, 2021 | 315.78 Mn |
| Jun 30, 2021 | 355.10 Mn |